Reflection Asset Management’s Pfizer PFE Stock Holding History

Reflection Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,940	Closed	-$148K	–	369
2025 Q4	$148K	Buy	+5,940	New	+$150K	0.11%	124

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Reflection Asset Management's PFE Position: Q1 2026 in Review

Reflection Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 5,940 shares — an estimated $148K sold.

Reflection Asset Management first reported a position in PFE in Q4 2025 and held it in 1 quarter. The position peaked at $148K in Q4 2025. 2,962 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Reflection Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Reflection Asset Management sold 5,940 Pfizer shares in Q1 2026, an estimated $148K.
Reflection Asset Management first reported a position in Pfizer in Q4 2025 and held it in 1 quarter.
Reflection Asset Management's Pfizer position peaked at $148K in Q4 2025.
2,962 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Reflection Asset Management's 13F filing for Q1 2026, filed 26 Aug 2026.